Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000912282-25-001424
Filing Date
2025-12-15
Accepted
2025-12-15 19:35:57
Documents
1
Period of Report
2025-12-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 9489
  Complete submission text file 0000912282-25-001424.txt   11094
Mailing Address C/O NEPHROS, INC. 380 LACKAWANNA PLACE SOUTH ORANGE NJ 07079
Business Address
Evans Daron (Reporting) CIK: 0001411726 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39683 | Film No.: 251573005

Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Issuer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)